Views & Analysis Will pharma get its own Brexit deal? After the Nissan deal, pharma is looking for similar reassurances
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face